HeartLung.AI
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2450 Holcombe Blvd, Houston, Texas, 7702...Phone Number
(310) 510-6004Website
www.heartlung.aiRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About HeartLung.AI
Focusing on preventing heart attack and lung cancer with supervised AI, mobile app, and noninvasive imaging. HeartLung received FDA Breakthrough Designation for AI-CAC that detects signs of heart disease in CT scans more accurately than humans.Explore more
HeartLung.AI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HeartLung.AI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
HeartLung.AI, which may be a good buyer, showed buying intent in Masked Content Topic
Check if HeartLung.AI has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on HeartLung.AI recently announced quarterly report
Product Launch: Get notified when HeartLung.AI launches new products
Funding: Get notified immidiatlly once HeartLung.AI has new funding data
Click to see if HeartLung.AI had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at HeartLung.AI
Check out if HeartLung.AI is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined HeartLung.AI as Masked Content
Find 2 more new buyers
Compare Similar Companies to HeartLung.AI
Compare insights from companies similar to HeartLung.AI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
HeartLung.AI is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
HeartLung.AI is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about HeartLung.AI.
HeartLung.AI Tech Stack
A closer look at the technologies used by HeartLung.AI
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
HeartLung.AI News & Media
After 36 Years, Coronary Calcium Score Gets Its First Major Upgrade (Agatston-2.0) Led by HeartLung.AI and Dr. Agatston
New study introduces an AI-based coronary calcium scoring method designed to address key limitations of the original Agatston score. HOUSTON, TX, UNITED STATES, June 12, 2026 /EINPresswire.com/ -- HeartLung Corporation today announced the publication of …Study Shows AI-CVD® Outperforms Diabetes in Predicting Heart Failure Risk
HOUSTON, TX, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- HeartLung Corporation announced the publication of a new study in the American Journal of Preventive Cardiology titled “Comparing Incidence of Heart Failure in Individuals with Enlarged …HeartLung.AI Emerges as a Leading Innovator in Cardiology with 10 Accepted ESC.26 Abstracts
Accepted studies showcase HeartLung.AI’s leadership in AI-CVD, opportunistic CT screening, Agatston 2.0, chamber volumetry, and preventive cardiology. HOUSTON, TX, UNITED STATES, May 11, 2026 /EINPresswire.com/ -- HeartLung.AI today announced that 10 …HeartLung Announces USPTO Issuance of Foundational AI-CVD Patent and Allowance for Vasa Vasorum Inflammation Imaging
New intellectual property milestones strengthen HeartLung’s leadership in AI–enabled preventive CT imaging and coronary inflammation assessment HOUSTON, TX, UNITED STATES, May 3, 2026 /EINPresswire.com/ -- HeartLung Corporation, a medical technology …
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding HeartLung.AI
Sign Up For FreeTo access detailed company insights
Focusing on preventing heart attack and lung cancer with supervised AI, mobile app, and noninvasive imaging. HeartLung received FDA Breakthrough Designation for AI-CAC that detects signs of heart disease in CT scans more accurately than humans.... Read More
